BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30476369)

  • 1. Tardive Oculogyric Crisis With Low-Dose Antipsychotic in an Adolescent: A Case Report.
    Gnanavel S
    Prim Care Companion CNS Disord; 2018 Nov; 20(6):. PubMed ID: 30476369
    [No Abstract]   [Full Text] [Related]  

  • 2. Not just another antipsychotic-for-conduct-problems trial.
    Blader JC
    J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):17-20. PubMed ID: 24342382
    [No Abstract]   [Full Text] [Related]  

  • 3. Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.
    Pérez CA; Garcia SS; Yu RD
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):182. PubMed ID: 26871198
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder.
    Karpuz D; Hallioglu O; Toros F; Tasdelen B
    J Electrocardiol; 2017; 50(4):410-415. PubMed ID: 28274540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A washout period needed before switching from a neuroleptic to an amphetamine.
    Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TD from risperidone?
    Edleman RJ
    J Am Acad Child Adolesc Psychiatry; 1997 Jul; 36(7):867. PubMed ID: 9204659
    [No Abstract]   [Full Text] [Related]  

  • 8. Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defiant disorder, and aggression: a prospective, open-label study.
    Kronenberger WG; Giauque AL; Lafata DE; Bohnstedt BN; Maxey LE; Dunn DW
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):334-47. PubMed ID: 17630867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of risperidone-induced tardive parkinsonism.
    Bolu A; Garip B; Öznur T; Uzun Ö
    Psychiatry Clin Neurosci; 2019 May; 73(5):285-286. PubMed ID: 30854755
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory.
    Farmer CA; Epstein JN; Findling RL; Gadow KD; Arnold LE; Kipp H; Kolko DJ; Butter E; Schneider J; Bukstein OG; McNamara NK; Molina BS; Aman MG
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):117-124. PubMed ID: 27348211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant-atypical antipsychotic interaction and acute dystonia.
    Benjamin E; Salek S
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510-2. PubMed ID: 15908830
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued.
    Keshen A; Carandang C
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):867-70. PubMed ID: 18315457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate-risperidone combination in child psychiatry: A retrospective analysis of 44 cases.
    Javelot H; Glay-Ribau C; Ligier F; Weiner L; Didelot N; Messaoudi M; Socha M; Body-Lawson F; Kabuth B
    Ann Pharm Fr; 2014 May; 72(3):164-77. PubMed ID: 24780832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oculogyric crisis as an isolated extrapyramidal symptom of auto-intoxication with risperidone].
    van Renterghem L; Titeca K; Crunelle CL; Geerts P; Matthys F
    Tijdschr Psychiatr; 2019; 61(9):649-653. PubMed ID: 31560785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone and tardive dyskinesia.
    Feeney DJ; Klykylo W
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421-2. PubMed ID: 8936904
    [No Abstract]   [Full Text] [Related]  

  • 16. Tardive oculogyric crisis associated with amisulpride monotherapy.
    Mendhekar DN; Lohia D; Kataria P
    J Postgrad Med; 2010; 56(4):305-6. PubMed ID: 20935407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.
    Elbe D; Barr AM; Honer WG; Procyshyn RM
    J Psychiatry Neurosci; 2014 May; 39(3):E32-3. PubMed ID: 24758945
    [No Abstract]   [Full Text] [Related]  

  • 18. Oculogyric crisis with exacerbation of psychosis: Possible mechanism and clinical implications.
    Thomas N; Sankar SS; Braganza D; Jayakrishnan S
    Neurosci Lett; 2009 Feb; 451(1):50-1. PubMed ID: 19121367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced extrapyramidal reactions.
    Teoh L; Allen H; Kowalenko N
    J Paediatr Child Health; 2002 Feb; 38(1):95-7. PubMed ID: 11869410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD Masquerading as Cautopyreiophagia Exacerbated by Risperidone and Improved With Methylphenidate in a Preschooler.
    Naguy A
    Prim Care Companion CNS Disord; 2021 Jul; 23(4):. PubMed ID: 34228405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.